Archive for the 'AstraZeneca' Category

AstraZeneca Recentin failed

AstraZeneca Plc is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead.
The mixed news on Wednesday adds to the company’s patchy record on drug research, analysts said.
Recentin, which is given as a pill, is [...]

FDA approved Nexium for kids

AstraZeneca Plc’s Nexium drug has been approved in the United States for treating excess stomach acid in children aged 1 to 11, the Food and Drug Administration (FDA) said on Thursday.
The FDA approved Nexium, Astra’s top seller and the world’s second-biggest prescription medicine, in two forms — a delayed response capsule and a liquid — [...]